Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints.

President Donald Trump’s approval rating went up in two polls this week, dipped slightly in another and held steady in two others—as surveys show Americans are nearly evenly split on views of ...

Topline President Donald Trump’s approval rating went up in two polls this week, dipped slightly in another and held steady in two others—as surveys show Americans are nearly evenly split on ...